Medtronic's next-gen heart implants clear EU regulatory hurdle

02/5/2013 | MassDevice.com (Boston)

European regulators have granted Medtronic CE mark approval to market a next-generation line of its Evera implantable cardioverter defibrillators. The newly approved product line comes with a more contoured and thinner design for improved fit within the body and as much as 11 years of battery life, according to the company.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD